MXC Official Launch Confirmed - MGC Derma’s CBD Herbal Cream for Relief of Psoriasis Symptoms
• MGC Pharmaceuticals’ (MXC) MGC Derma Division has today officially launched its first Derma Plus product, for relief of psoriasis symptoms
• The Derma Plus product is the CBD Herbal Repair Cream, specifically developed for relief of mild forms of psoriasis
• The Derma Plus range, comprising 3 products, completed successful clinical tests at a leading independent European dermatological clinic during H2 2017
• Results from the independent testing confirmed the product’s efficacy for the relief of a range of highly irritated or inflamed skin conditions
• The two additional Derma Plus products for relief from acne and dermatitis conditions, the Herbal Balm and Herbal Replenish Cream, are also planned for launch during Q1 2018
MXC Welcomes Australian Government Move to Legalise Medicinal Cannabis Exports
• MXC welcomes announcement by Australian Government to allow the export of medicinal cannabis products
• Ensures the Company can strengthen its focus on a development plan for future Australian operations with a clear federal legislative and regulatory framework now expected to be in place during February 2018
• MXC has established a clear pathway for building Australian demand and initial market for its medicinal cannabis products through its agreement with HL Pharma
• MXC’s first pharmaceutical grade medical cannabis product CannEpil planned for launch in Australia in 2018 with HL Pharma as announced on 19 November 2017
Distribution Agreement Signed with Leading Global Online Cosmetics Store - Cult Beauty
• MGC Pharmaceuticals’ (MXC’s) European subsidiary, MGC Derma, has signed a strategic distribution agreement with world renowned online beauty store, Cult Beauty
• Deal will see 15 of MGC Derma’s cosmetics products sold on the Cult Beauty site, and its Derma Plus skin care range
• Cult Beauty will run a 6-month exclusive sales campaign on the MGC Derma products
• MGC Derma’s cosmetics will officially be launched by Cult Beauty on 1 February 2018
• Cult Beauty is a UK-based online beauty store that specialises in selling cutting edge, and hardto-find beauty products to consumers around the world
Initial GMP Certification Granted for European Medicinal Cannabis Manufacturing Facility
Certification Enables CannEpil Production to Commence Immediately
• MGC Pharma has been formally granted interim GMP Certification for its European Medicinal Cannabis Manufacturing facility
• Follows 18-month facility construction and work process - upon full GMP certification, MXC’s facility will be one of the most advanced in Europe for pharmaceutical grade medical cannabis production
• MXC now approved to produce first batch of CannEpil at the facility following receipt of the interim GMP certification
• Interim licence issue is one of the final steps for full GMP certification
• Once CannEpil is fully approved for distribution in Australia, this is expected to generate in excess of $1m annually in sales in its first year
• MXC on track to complete GMP certification for its extraction facility, to deliver a fully integrated GMP facility for production and development of pharmaceutical grade medicinal products and formulations
• Major operational achievements across all three divisions, material contracts with near term revenue generation potential signed during the quarter
• MGC Pharma division: GMP certification process well advanced as Company prepares for first production of CannEpil and an Australian launch in 2018
• Multi-year agreement and purchase order signed for the supply of CBD extract, with first revenues from Masbut Life received
• MGC Botanic division: First harvests yield in Slovenia and Czech Republic with total over 4,400kg biomass which is being processed for use in the production of MGC’s Derma and Pharma products
• MGC Derma division: First binding agreement signed with Varm Cosmo for supply of white label cosmetic products in 2018
• New Derma Plus product CBD Herbal Repair cream is launched, with an additional two products on track for Q1 2018 launch
• +$8m cash at bank, ensuring MXC is well funded in the lead up to its first production of CannEpil and focuses on securing additional commercial contracts, generating near term revenue from multiple product lines
Cult Beauty confirms official sales launch of MGC Derma and Derma Plus cosmetic ranges
• MGC Pharmaceuticals’ (MXC’s) range of MGC Derma and Derma Plus products has today been officially launched on leading global online cosmetics store, Cult Beauty
• The launch follows the execution of a strategic distribution agreement between MXC’s European subsidiary, MGC Derma and Cult Beauty last month
• 15 of MGC Derma’s cosmetics products and its Derma Plus skin care range, developed for the relief of highly inflamed and irritated skin conditions, are now being sold on the global Cult Beauty site
• The launch is supported by a 6-month exclusive sales campaign on MGC Derma products and additional promotional activities, with feature articles already secured in leading industry publications
• Cult Beauty is a UK-based online beauty store that specialises in selling cutting edge, and hard-to-find beauty products to consumers around the world
MXC Price at posting:
11.5¢ Sentiment: None Disclosure: Held
(20min delay)